STANDARTIZATsIYa LABORATORNOGO TESTA DLYa OPREDELENIYa PROSTATIChESKOGO SPETsIFIChESKOGO ANTIGENA

Citar

Texto integral

Catalona W., J., Hudson M. A., Scardino P. T. et al. Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves. J. Urol. (Baltimore) 1994; 152: 2037-2042.
Semjonow A., Brandt B., Oberpenning F., Hertle L. Different determination methods make interpretation of prostate-specific antigen more difficult. Urologe A. 1995; 34: 303-315.
Stamey T. A., Teplow D. B., Graves H. C. Identity of PSA purified from seminal fluid by different methods: comparison by amino acid analysis and assigned extinction coefficients. Prostate 1995; 198-203.
Link R. E., Shariat S. F., Nguyen C. V. et al. Variation in prostate specific antigen results from 2 different assay platforms: clinical impact on 2304 patients undergoing prostate cancer screening. J. Urol. (Baltimore) 2004; 171: 2234-2238.
Semjonow A., Albrecht W., Bialk P. et al. Tumour markers in prostate cancer: EGTM recommendations. Anticancer Res. 1999; 19: 2799-2801.
Kwiatkowski M., Seiler D., Huber A., Recker F. Clinical implications for use of various PSA assays in prostate cancer early detection. J. Urol. (Baltimore) 2007; 177: 4 (suppl.): 533.
Blijengberg B. G., Storm B. N., Kruger A. E., Schroder F. H. On the standardization of total prostate-specific antigen: an exercise with two reference preparations. Clin. Chem. Lab. Med. 1999; 37: 545-552.

Ação

1. JATS XML